Fingerprint
Dive into the research topics of 'Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
Daniel P. Petrylak, Catherine M. Tangen, Maha H.A. Hussain, Primo N. Lara, Jeffrey A. Jones, Mary Ellen Taplin, Patrick A. Burch, Donna Berry, Carol Moinpour, Manish Kohli, Mitchell C. Benson, Eric J. Small, Derek Raghavan, E. David Crawford
Research output: Contribution to journal › Article › peer-review
3083
Scopus
citations